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Necroptosis is a form of programmed cell death that
is defined by activation of the kinase RIPK3 and sub-
sequent cell membrane permeabilization by the
effector MLKL. RIPK3 activation can also promote
immune responses via production of cytokines and
chemokines. How active cytokine production is co-
ordinated with the terminal process of necroptosis
is unclear. Here, we report that cytokine production
continues within necroptotic cells even after they
have lost cell membrane integrity and irreversibly
committed to death. This continued cytokine pro-
duction is dependent on mRNA translation and
requires maintenance of endoplasmic reticulum
integrity that remains after plasma membrane integ-
rity is lost. The continued translation of cytokines by
cellular corpses contributes to necroptotic cell up-
take by innate immune cells and priming of adaptive
immune responses to antigens associated with nec-
roptotic corpses. These findings imply that cell death
and production of inflammatory mediators are coor-
dinated to optimize the immunogenicity of necrop-
totic cells.
INTRODUCTION
Programmed cell death can occur via several pathways, and the
way a cell dies influences subsequent immune responses (Yatim
et al., 2017). Although apoptosis is generally considered immu-
nologically silent, lytic forms of cell death, such as pyroptosis
and necroptosis, can occur in response to pathogenic infection
and are associated with inflammation and adaptive immunityCell Re
This is an open access article und(Green and Llambi, 2015). It is now appreciated that these cell
death programs influence the immune system through the active
generation of immunostimulatory signals during cell death. The
activating cleavage of interleukin-1b (IL-1b) and IL-18 by cas-
pase-1 that accompanies pyroptosis is a well-described
example of this paradigm (de Vasconcelos et al., 2016; Vande
Walle and Lamkanfi, 2016).
Necroptosis is a distinct cell death program, triggered in
response to receptor ligation or viral infection through formation
of a cytosolic complex containing the receptor-interacting pro-
tein kinases RIPK1 (Degterev et al., 2008; Lin et al., 2004) and
RIPK3 (Cho et al., 2009; He et al., 2009; Zhang et al., 2009)
and subsequent phosphorylation of the membrane-disrupting
pseudokinase MLKL (Chen et al., 2013; Sun et al., 2012; Wu
et al., 2013; Zhao et al., 2012). Several recent studies have high-
lighted additional roles for the RIP kinases in promoting nuclear
factor kB (NF-kB)-dependent transcriptional responses, which in
some cases occur simultaneously with necroptotic cell death
(Snyder et al., 2019; Yatim et al., 2015). We have previously re-
ported that this transcriptional signaling leads to an increase in
cross-priming of T cells responsive to antigens derived from nec-
roptotic cells. However, this finding raises the question of how a
necroptotic cell is able to actively generate immunostimulatory
cytokines while committing to the terminal process of cell death.
Notably, an older report indicated that, although caspase activa-
tion associated with apoptosis actively suppresses protein
translation by cleaving translation initiation factors, necroptotic
cells retain the ability to translatemRNAs up to the point of death,
as defined by loss of membrane integrity (Saelens et al., 2005).
Here, we report that cells undergoing necroptosis in response
to direct RIPK3 activation or viral infection continue de novo syn-
thesis of cytokines and chemokines for several hours after they
have lost plasma membrane integrity and irreversibly committed
to cell death. This process involves continued mRNA translation
in cellular ‘‘corpses’’ and proceeds via an endoplasmic reticulumports 28, 2275–2287, August 27, 2019 ª 2019 The Author(s). 2275
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. RIPK3 Activation Leads to Transcriptional Changes and to Cytokine Synthesis that Continues after Loss of PM Integrity
(A) Schematic representation of RIPK3 and the chimeric RIPK3 construct used in this study.
(B) NIH 3T3 fibroblasts expressing acRIPK3 were treated with dimerizer drug for the indicated times and analyzed for the uptake of the cell-impermeable dye
Sytox Green by flow cytometry.
(legend continued on next page)
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(ER)-dependent mechanism that reflects maintenance of ER
integrity after MLKL-mediated plasma membrane (PM) permea-
bilization. This continued cytokine and chemokine synthesis
enhances the uptake of necroptotic-cell-derived material and
contributes to the immunogenicity of necroptotic cell-derived
antigens in vivo. Together, these findings define an unexpected
mechanism by which cells that have irreversibly committed to
cell death continue to influence inflammatory and immune
responses.
RESULTS
RIPK3 Activation Leads to Cytokine Synthesis that
Continues after Loss of PM Integrity
To study the effects of RIPK3 activation, we employed a previ-
ously described system in which RIPK3 can be activated
directly, independent of upstream receptor signaling (Orozco
et al., 2014). Briefly, we created a chimeric form of RIPK3,
composed ofmurine RIPK3 fused to tandemcopies of the dimer-
izable domain FKBPF36V. We term the resulting chimeric, activat-
able RIPK3 construct ‘‘acRIPK3’’ (Figure 1A). Consistent with
previous reports (Orozco et al., 2014; Yatim et al., 2015), clonal
populations of NIH 3T3 cells expressing acRIPK3 underwent
rapid and uniform necroptosis upon addition of the small-mole-
cule dimerizer drug, as measured by the uptake of the cell-
impermeable DNA-binding dye Sytox Green. We observed that
>99% of cells were positive for Sytox Green 3 h after addition
of dimerizer (Figure 1B). The robust induction of necroptosis by
this systemwas further confirmed by kinetic imaging using an In-
cuCyte system, release of lactate dehydrogenase (LDH), and
CellTiter-Blue viability assay (Figure S1A).
We next assessed the transcriptional changes associated with
RIPK1-RIPK3 complex formation using poly-A enrichment and
RNA sequencing. We found that direct activation of RIPK3 led
to increased transcription of numerous genes encoding inflam-
matory mediators. This response closely mirrored the transcrip-
tional signature observed upon treatment of these cells with
tumor necrosis factor alpha (TNF-a), reflecting the common
recruitment of RIPK1 to both activated RIPK3 and TNFR1 (Fig-
ure 1C). We next performed RNA sequencing on cells at various
time points following RIPK3 activation. Increased transcription of
inflammatory mediators was observable 30 min after RIPK3 acti-
vation (Figure S1B), and these continued to increase in samples
collected 1 and 2 h after RIPK3 activation (Figure S1C). This tran-
scriptional response plateaued by 3 h after RIPK3 activation, as
samples collected at this time point or 1 h later showed few
changes to the identity or abundance of mRNA species present(C) NIH 3T3 cells expressing acRIPK3 were treated with TNF-a or RIPK3 was activ
was performed and transcript abundance relative to untreated controls analyzed.
depicted in red, y axis only in green, and both axes in blue.
(D) ELISA analysis of indicated cytokines in the supernatant of NIH 3T3 cells ind
(E and F) Kinetic comparison of Sytox Green uptake (black lines) versus de novo
either actinomycin D (ActD) or cycloheximide (CHX) 30 min before dimerizer tre
roptosis and were subsequently treated with ActD or CHX 3 h later. IL-6 in the s
(G) Experimental schematic for data in (H).
(H) NIH 3T3 cells were treated as in (G) and supernatants analyzed by ELISA. Value
representative of at least three independent experiments.
Error bars indicate SD from the mean.(Figures S1D and S1E). As >99% of these cells lose PM integrity
by 3 h after RIPK3 activation (Figure 1B), these observations are
consistent with RIPK3 activation leading to a robust transcrip-
tional program, which is curtailed upon cell lysis.
Given the concurrence of inflammatory transcription and cell
death upon RIPK3 activation, we next wondered how the trans-
lation of these mRNA species into cytokines and chemokines
was regulated during necroptosis. To assess this, we measured
the accumulation of cytokines in cellular supernatants following
RIPK3 activation, focusing on IL-6, CXCL1, CXCL2, and CCL2,
each of which was upregulated by RIPK3 at the mRNA level.
Consistent with RIPK3-dependent production of these media-
tors, we found that RIPK3 activation led to their accumulation
in cellular supernatants, which was curtailed by addition of a
small-molecule RIPK3 inhibitor (GSK’843), but not by the
RIPK1 inhibitor necrostatin-1 (Figure S1F). Consistent with
earlier reports of a scaffolding function for RIPK1 in this setting
(Yatim et al., 2015), the use of a form of RIPK3 lacking a RHIM
domain, which is unable to interact with RIPK1 (Orozco et al.,
2014), induced robust cell death but failed to induce concurrent
cytokine production (Figure S1G).
Given our observation that transcription of mRNAs following
RIPK3 activation appeared to cease upon cell lysis, we next car-
ried out kinetic analyses to see whether mRNA translation fol-
lowed a similar pattern. In contrast to our observations of
mRNA abundance, this analysis revealed that the quantities of
inflammatory cytokines in cellular supernatants continued to in-
crease up to 9 h after activation of RIPK3 (Figure 1D). This was
unexpected, as these cells had uniformly lost PM integrity by
3 h after RIPK3 activation (Figures 1B and S1A).
These findings implied that necroptotic cells may continue to
produce inflammatory cytokines even after the irreversible loss
of cell membrane integrity and commitment to cell death. To
test this idea, we assessed the effect of inhibiting transcription
or translation, either before RIPK3 activation or after RIPK3-
and MLKL-mediated loss of cell-membrane integrity, in each
case measuring abundance of IL-6 protein as a marker of the
RIPK3-dependent inflammatory response. We found that addi-
tion of either actinomycin D (ActD) or cycloheximide (CHX),
which inhibit transcription and translation, respectively, to cells
prior to RIPK3 activation abolished IL-6 production during nec-
roptosis, consistent with de novo transcription and translation
of IL-6 (Yatim et al., 2015; Figure 1E). We next activated RIPK3
and then waited 3 h, a time point at which >99% of cells have
lost membrane integrity (Figure 1B). Addition of ActD to these
cellular corpses did not alter continued accumulation of cyto-
kines in the supernatant, consistent with our observation thatated by addition of dimerizer. 4 h later, poly-A enrichment and RNA sequencing
Values reaching significance (fold change [FC] > 1; p < 0.05) on x axis only are
uced to undergo necroptosis via activation of acRIPK3.
IL-6 production. (E) NIH 3T3 cells expressing acRIPK3 were pre-treated with
atment. (F) NIH 3T3 cells expressing acRIPK3 were induced to undergo nec-
upernatant was quantified by ELISA.
s are plotted as fold increase in IL-6 after Sytox Green uptake (3 h). All data are
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Figure 2. Ongoing Translation in Necroptotic Corpses Is Associated with the ER
(A) NIH 3T3 cells expressing acRIPK3 were treated for 3 h with dimerizer and analyzed by TEM. Solid purple arrows indicate intact ER; yellow dashed arrows
indicate disrupted plasma membrane; ‘‘N’’ indicates nucleus. Scale bar in left panel represents 2 mm. Scale bars in middle and right panels represent 400 nm.
(B–D) NIH 3T3 cells expressing acRIPK3 were induced to undergo necroptosis and then treated with either digitonin (B), brefeldin A (BfA) (C), or thapsigargin (D)
after 3 h (/). The concentration of cytokine in the supernatant was quantified at 9 h post-dimerizer addition.
(E) Experimental schematic for data in (F).
(F) Cells were treated as in (E), and intracellular CCL2 was analyzed by flow cytometry. The gating for both histogram (left panel) and geometric mean fluorescent
intensity (gMFI; right panel) is all cells > singlets > Zombie Green+.
(legend continued on next page)
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de novo transcription has ceased at this time point (Figures S1D
and S1E). However, addition of CHX at this time point abrogated
further increase in cytokine levels in cellular supernatants (Fig-
ure 1F). This finding implies that protein translation, but not tran-
scription, continues in necroptotic cell corpses following the loss
of membrane integrity, allowing for continued production and
accumulation of inflammatory cytokines.
A recent study demonstrated that the ESCRT-III machinery
can act downstream of MLKL to regulate necroptotic death
and sustain cell survival (Gong et al., 2017). We therefore sought
to confirm that uptake of Sytox Green was an accurate marker of
irreversible loss of cell-membrane integrity. To do this, we made
use of a competitive inhibitor of the dimerizer drug, termed
washout ligand (WL). We first added dimerizer drug to activate
RIPK3 in our acRIPK3 cell line and then added WL in the pres-
ence of Sytox Green, waited 24 h, and then treated cells with
another cell-impermeable dye, Yoyo-3 (Figure S1H). We hypoth-
esized that, if cells transiently permeabilized their membranes
and then recovered, we would detect a population of cells that
becamemarked with Sytox Green and then regained membrane
integrity sufficiently to exclude Yoyo-3. However, we did not
observe this; all cells that lost membrane integrity upon RIPK3
activation (Sytox Green positive) remained permeable 24 h later
(Yoyo-3-positive; Figure S1I). Consistent with these data, we
found that, after 3 h of RIPK3 activity, the potential for clonogenic
outgrowth was irrecoverably lost (Figure S1J). These data indi-
cate that loss of cell-membrane integrity, as indicated by uptake
of Sytox Green, is an irreversible event from which cells do not
recover.
We next sought to understand whether the ongoing mRNA
translation we observed occurred within necroptotic corpses;
in an extracellular compartment, such as an exosome; or on
free ribosomes released into the culture supernatant. To address
this question, we fractionated necroptotic cells by low-speed
centrifugation and analyzed further cytokine synthesis in either
supernatant or cell corpses (Figure 1G). We observed that iso-
lated corpses, but not their supernatants, had the same increase
in IL-6 levels as unseparated necroptotic cell cultures. Addition
of CHX to cell corpses following isolation from supernatants
inhibited further cytokine synthesis (Figure 1H). These data sug-
gest that ongoing translation following loss of PM integrity
occurs within the necroptotic corpse. Together, these findings
indicate that the translation of mRNA continues within necrop-
totic cell bodies even after PM integrity is irreversibly lost.
Ongoing Translation in Necroptotic Cell Corpses Is
Associated with the ER
We performed transmission electron microscopy on necroptotic
cells 3 h after RIPK3 activation. We observed that, although the
PM was clearly disrupted at this time point, sections of ER stud-
ded with ribosomes remained intact (Figures 2A and S2A, yellow
and purple arrows, respectively). This observation led us to(G) Experimental schematic for data in (H).
(H) NIH 3T3 cells expressing acRIPK3 were treated as in (G) and analyzed by m
represent 10 mm.
Data in (A) are representative of one independent experiment. Data in (B)–(D)
****p < 0.0001; ***p < 0.001; **p < 0.01; *p < 0.05. nd, not detected; NS, not signconsider whether these or other membranous structures within
cell corpses were required to support ongoing translation. To
assess this, we treated cells with the detergent digitonin, using
a concentration sufficient to permeabilize all cellular mem-
branes. Although digitonin did not directly affect ribosome
function in an in vitro assay (Figure S2B), adding digitonin to nec-
roptotic corpses abolished ongoing translation (Figure 2B). To
further investigate a possible role for preserved ER function in
continued translation, we treated necroptotic cell corpses with
brefeldin A (BfA), an inhibitor of protein transport from the ER
to the Golgi apparatus (Figure 2C), or with thapsigargin, a disrup-
tor of ER calcium homeostasis (Figure 2D). Each of these re-
agents abrogated ongoing production of IL-6 in necroptotic
cell corpses. Together, these data implicate continued ER func-
tion within necroptotic corpses as a requirement for continued
cytokine translation.
One possible explanation for the observation of continued
protein translation within necroptotic cells would be the pres-
ence of an undetected population of viable cells in our cultures.
Given our findings indicating that translation occurs within
cellular corpses, we devised an assay that allowed us to quantify
cytokine translation within individual necroptotic cells. To do
this, we induced necroptosis in NIH 3T3 cells and then briefly
pulsed them with a cell-impermeable dye (Zombie Green) to
mark only cells that had lost membrane integrity at this time
point. These cellular corpses were then incubated with BfA to
allow the accumulation of cytokines within the ER and subjected
to intracellular cytokine staining and flow cytometry (Figure 2E).
By analyzing only those cells marked by the pulse of cell-imper-
meable dye, we were thereby able to quantify cytokine accumu-
lation in individual cells that were confirmed to have lost PM
integrity. We found that these corpses showed a significant in-
crease in accumulation of CCL2 after loss of membrane integrity.
Importantly, if CHX was added to these cells after PM integrity
loss, this increase was abrogated (Figure 2F), consistent with
continued mRNA translation in cells lacking PM integrity.
We next sought to directly visualize protein translation in nec-
roptotic cell corpses using puromycilation, wherein puromycin
is covalently incorporated into growing polypeptide chains
by active ribosomes. These puromycilated polypeptides can
then be detected using a monoclonal antibody to puromycin
(Schmidt et al., 2009). We first pulsed necroptotic cell corpses
with the cell-impermeable dye Zombie Green to confirm loss of
PM integrity and then washed out excess dye before pulsing
them with puromycin (Figure 2G). As expected, when this assay
was applied to live cells, we observed no incorporation of
Zombie Green but robust incorporation of puromycin, which
was blocked by co-incubation with the translation inhibitor
CHX (Figure 2H). In necroptotic cells, we observed uptake of
Zombie Green consistent with loss of PM integrity but also
clear incorporation of puromycin into newly synthesized poly-
peptides, suggesting ongoing translation in these cells. Notably,icroscopy. Representative images for each condition are shown. Scale bars
, (F), and (H) are representative of at least three independent experiments.
ificant. Error bars indicate SD from the mean.
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Figure 3. Ongoing Translation Is Permitted by a Lack of ER Disruption by MLKL and Occurs during Necroptosis Induced by CMV, IAV,
and TNF
(A–C) NIH 3T3 + acRIPK3 cells expressing MLKL-ERcb5 or vector control were pre-treated with doxycycline for 4 h and then treated with dimerizer to induce
necroptosis. Cells were pulsed with the cell-impermeable dye Zombie Green and then stained with antibodies against pMLKL and ERp72. (A) Cells were analyzed
by microscopy. Representative images for each condition are shown. Scale bars represent 10 mm. (B) Quantification of normalized colocalization ([red + blue
signal]/[blue signal]) from (A). (C) IL-6 and CXCL2 levels in the supernatant were quantified by ELISA at 18 h post-dimerizer addition.
(D and E) SVEC4-10 cells with intact (scramble gRNA) or CRISPR/Cas9-disrupted RIPK3 (RIPK3 gRNA) were infected with MCMV M45DRHIM (MOI = 1), and
death kinetics were analyzed via IncuCyte bioimaging (D) or imaged by microscopy (E). Representative images for each condition in (E) are shown. Scale bars
represent 10 mm.
(legend continued on next page)
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puromycilated polypeptides co-localized with the ER marker
ERp72 (Figure 2H), consistent with the idea that the ER is the
site of ongoing translation in necroptotic cells. Also consistent
with this, we did not observe puromycin incorporation (and
thus ongoing translation) in cells in which intracellular mem-
branes were disrupted by digitonin (Figure S2C). Together, these
data implicate continued ER function within necroptotic corpses
as a requirement for ongoing translation.
MLKL Fails to Completely Disrupt the ER during
Necroptosis
Activated phosphorylatedMLKL (pMLKL), the executioner mole-
cule of necroptosis, has been shown to translocate to the PM
and disrupt its integrity. Although imaging studies have indicated
that most activatedMLKL localizes to the PM, the ability ofMLKL
to disrupt other cellular membranes is less clear (Cai et al., 2014;
Dondelinger et al., 2014; Gong et al., 2017; Quarato et al., 2016;
Wang et al., 2014). Given our finding of ongoing translation
following MLKL-mediated PM disruption and our implication of
the ER in this process, we hypothesized that activated MLKL
does not efficiently disrupt this organelle during necroptosis.
Consistent with this idea, we observed limited co-localization
of phosphorylated MLKL and the ER marker ERp72 following in-
duction of necroptosis (Figures 3A and 3B).
If a failure by MLKL to disrupt the ER during necroptosis is
required to allow protein synthesis to continue, we reasoned
that targeting MLKL to the ER might induce its disruption during
necroptosis and thereby abolish this phenomenon. To test this,
we engineered an MLKL construct targeted to the cytoplasmic
surface of the ER, through addition of a sequence derived from
the C terminus of cytochrome b5 (Wang et al., 2001). As ex-
pected, in corpses expressing both endogenous and ER-tar-
geted MLKL, we observed increased co-localization of pMLKL
and the ER following RIPK3 activation (Figures 3A and 3B).
Notably, expression of this ER-targeted MLKL did not affect
the kinetics of necroptosis, as cells also expressed endogenous
MLKL to allow PM disruption (Figure S3A). However, in cells ex-
pressing ER-targeted MLKL, we observed a reduction in cyto-
kine and chemokine production after PM disruption (Figure 3C).
Taken together, these data suggest that, upon RIPK3 activation,
MLKL selectively targets the PM, allowing for continued ER-
dependent translation even after loss of PM integrity.
TNF- or Virus-Induced Necroptosis Leads to Continued
Translation after Loss of PM Integrity
Several viruses have been shown to induce RIPK3-dependent
death through activation of the nucleotide sensor DAI/ZBP1
(Guo et al., 2018; Koehler et al., 2017; Kuriakose et al., 2016; No-
gusa et al., 2016; Thapa et al., 2016; Upton et al., 2012), so we
sought to determine whether translation occurs following
necroptotic PM rupture induced by viral infection. To test this,(F and G) SVEC4-10 cells with intact or disrupted RIPK3 were infected with X31 in
or imaged by microscopy (G). Representative images for each condition in (G) a
(H) SVEC4-10 cells were subjected to TNF-a + zVAD treatment, and death kinet
(I) SVEC4-10 cells were treated with TNF-a + zVAD for 3 h, followed by addition an
puromycin (as illustrated in Figure 2G). All data are representative of at least two
from the mean.we used a mutant strain of murine cytomegalovirus (MCMV
M45DRHIM) that triggers robust necroptosis. Consistent with
previous reports (Upton et al., 2012), SVEC4-10 endothelial cells
expressing endogenous RIPK3 underwent RIPK3-dependent
cell death upon infection with this virus (Figures 3D and S3B).
To assess whether protein translation continued in these cells
following PM lysis, we took advantage of the intracellular cyto-
kine staining and puromycilation assays already described.
Flow cytometric analysis indicated that CCL2 and IL-6 continued
to accumulate in MCMV-killed cellular corpses after loss of PM
integrity and that this effect was abrogated by blocking transla-
tion with CHX after PM rupture (Figures S3C and S3D).
Consistently, imaging analysis of MCMV-killed cells following
puromycin pulse treatment revealed that puromycin was incor-
porated into the proteome of cells that had lost PM integrity
and that this puromycin incorporation could be blocked by inhib-
iting translation after loss of PM integrity (Figures 3E and S3E).
As influenza has also been shown to trigger RIPK3-dependent
necroptosis (Nogusa et al., 2016; Thapa et al., 2016), we carried
out analogous experiments following influenza infection. We first
confirmed that SVEC4-10 cells died in response to infection
with X31 influenza in a RIPK3-dependent manner (Figure 3F)
and then subjected infected cells to the puromycilation assay.
Analogous to our observations using MCMV M45DRHIM infec-
tion, we observed puromycin incorporation in cells that lost PM
integrity due to X31 influenza infection (Figure 3G). Again, this
translation could be blocked by treating infected cells with
CHX (Figure S3F).
Treatment with TNF-a in combination with the caspase inhib-
itor zVAD is a canonical necroptosis-inducing stimulus, and we
wondered whether mRNA translation continued following TNF-
a-induced necroptosis. To test this, we carried out puromycila-
tion experiments on SVEC cells treated with TNF-a + zVAD.
Consistent with our findings using other stimuli, we found that
translation continued after loss of PM integrity in these necrop-
totic cells (Figures 3H, 3I, and S3G). Together, these data indi-
cate that continued translation after PM rupture is a feature of
necroptosis induced by viral infection or TNF-a stimulation.
Cytokine and Chemokine mRNAs Are Associated with
Translating Polyribosomes in Necroptotic Corpses
We next evaluated whether the program of ongoing translation
observed in necroptotic cells was selective for specific mRNA
species. To assess this, we subjected live cells and necroptotic
corpses to polyribosome (polysome) analysis (Chasse´ et al.,
2017). Briefly, NIH 3T3 cells with acRIPK3 were induced to un-
dergo necroptosis using RIPK3 dimerization, and 4 h later (a
time point at which >99% of cells had lost PM integrity, as in Fig-
ure 1B), lysates from these cells were fractionated by sucrose
gradient ultracentrifugation, causing mRNAs associated with
multiple ribosomes (polysomes, the translating fraction) tofluenza (MOI = 1), and death kinetics were analyzed via IncuCyte bioimaging (F)
re shown. Scale bars represent 10 mm.
ics were analyzed via IncuCyte imaging.
d wash-out of the cell-impermeable dye Zombie Green prior to incubation with
independent experiments. ***p < 0.001; ****p < 0.0001. Error bars indicate SD
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Figure 4. Cytokine and Chemokine mRNA Is Associated with Translating Polyribosomes in Necroptotic Corpses
(A) Experimental schematic for polyribosome (polysome) analysis.
(B and C) RNA was extracted from the fractions corresponding to polysome peaks, and mRNA transcripts were analyzed by qPCR. Graphs represent the ratio of
total cytokine transcripts for RIPK3-dependent (B) and -independent (C) genes to a housekeeping gene (GAPDH) being actively translated in each condition.
(D) mRNA from whole necroptotic corpses, or from polysome fractions isolated from these corpses, was analyzed by RNA sequencing. Fold change relative to
untreated cells or polysomes isolated from untreated cells (respectively) is depicted. Values reaching significance (FC > 1; p < 0.05) on x axis only are depicted in
red and those significant on both axes in blue.
(E) NIH 3T3 + acRIPK3 cells were induced to undergo necroptosis with dimerizer, and the amount of ATP present in cells at the indicated time points was as-
sessed using CellTiter-Glo.
(F) NIH 3T3 + acRIPK3 were treated with dimerizer, digitonin, or treated with dimerizer followed by digitonin (/). 4 h later, ATP levels were quantified using
CellTiter-Glo. All data are representative of three independent experiments. NT, no treatment.
Error bars indicate SD from the mean.separate from freemRNAs or those associated withmonosomes
(non-translating fractions). Gradients were then fractionated
while continuously monitoring absorbance at 254 nm, giving
rise to polysome profiles (Figure 4A). In these experiments,
CHX is added to freeze ribosomes to mRNA to allow fraction-
ation, and EDTA, which dissociates ribosomes from mRNA, is
used as a negative control. Using this approach, untreated cells2282 Cell Reports 28, 2275–2287, August 27, 2019or cells treated with TNF-a were found to display the expected
profile of monosomes and polysomes (Figure S4A). Although
necroptotic corpses had a reduced polysome peak (Figure S4A),
we could nonetheless detect abundant cytokine and chemokine
transcripts by qPCR in the corresponding fractions (Figure 4B).
Interestingly, polysomes isolated from necroptotic corpses
were enriched for cytokine and chemokine transcripts (relative
to the housekeeping gene GAPDH), as compared to non-treated
or TNF-a-treated cells (Figure 4B). For comparison, we also
quantified the translation of CCL5, a gene we have observed to
be induced by TNF-a treatment, but not RIPK3 activation (Fig-
ure 4C), and found that it was not associated with ribosomes in
necroptotic corpses. Confirming that our fractionation was suc-
cessful, we found that input lysates (taken prior to polysome
fractionation) contained similar total transcript levels between
samples that were treated with either CHX or EDTA (Figure S4B);
however, EDTA treatment abolished the association of mRNAs
with polysome fractions, as expected (Figure S4C). These data
indicate that, upon RIPK3 activation, necroptotic cells upregu-
late cytokine and chemokine transcripts and that translation of
these mRNAs is associated with polyribosomes even after loss
of cell membrane integrity.
To test whether this reflected selective translation of cytokine
and chemokine transcripts, we carried out unbiased RNA
sequencing on polysome-associated mRNA fractions from nec-
roptotic cells and compared the results to total RNA obtained by
poly-A enrichment. This analysis revealed a strong correlation
between these two pools of mRNA: the most abundant tran-
scripts present in necroptotic corpses were also the most abun-
dant in the actively translating fraction (Figure 4D). This finding
indicates that ongoing protein translation in necroptotic cells is
not selectively directed toward specific mRNA species. Notably,
however, as shown in Figure 1C, the activation of RIPK3 leads to
robust transcriptional upregulation of inflammatory mediators at
the mRNA level, and these mediators therefore represent the
most differentially expressed transcripts present in necroptotic
corpses. These data therefore suggest that ongoing translation
in necroptotic cells is not selective for specific mRNA transcripts
but is biased toward production of inflammatory mediators by
accumulation of mRNA encoding these mediators following
RIPK3 activation.
Because protein translation is an energy-intensive process
(Buttgereit and Brand, 1995), we sought to determine ATP levels
in necroptotic corpses using CellTiter-Glo. Relative to their live-
cell counterparts, necroptotic corpses lost much of their ATP by
4 h after RIPK3 activation, a time point corresponding to
completed loss of PM integrity; however, these corpses main-
tained low but detectible levels of ATP even up to 12 h post-di-
merizer addition (Figure 4E). Given that global translation
appears to be diminished in necroptotic corpses (Figure S4A)
and that the ATP content of normal cells is several fold higher
than the minimum required for protein translation (Jewett et al.,
2009; Patel et al., 2017), we reasoned that perhaps this residual
ATP is sufficient to maintain translation. We hypothesized that
this residual ATP may be maintained by the architecture of
organellemembranes present in necroptotic corpses, consistent
with our finding that maintenance of ER function is required for
ongoing translation. Consistent with the possibility, addition of
digitonin to necroptotic corpses, which aspecifically disrupts
cell membranes, diminished ATP to nearly undetectable levels
(Figure 4F) and also halted translation (Figure 3B). These data
suggest that necroptotic corpses that have lost cell membrane
integrity maintain low levels of ATP and that this is sufficient to
allow ongoing translation of cytokines and chemokines in
corpses.Translation of Inflammatory Mediators within
Necroptotic Cells Influences Myeloid Cell Migration and
Promotes CD8+ T Cell Responses to Necroptotic Cell-
Derived Antigen
We next sought to evaluate the immunological consequences of
continued translation of inflammatory mediators within necrop-
totic cell corpses. We first assessed whether blocking this trans-
lation program in necroptotic corpses affected phagocytosis of
necroptotic cells in vitro by ‘‘feeding’’ necroptotic cells labeled
with fluorescent nanoparticle FluoSpheres to bone marrow-
derived macrophages (BMDM) cells (Figures 5A and S5A). To
assess the effect of ongoing translation on this process, we
also tested the effect of transiently pulsing necroptotic corpses
with emetine, an irreversible translation inhibitor, to halt ongoing
translation in these cells (Grollman, 1968; Figures S2B and S5B).
We found that emetine treatment reduced the efficiency with
which necroptotic cell material was taken up by phagocytes (Fig-
ure 5B), consistent with the possibility that chemokine produc-
tion by necroptotic cells promotes their phagocytosis. We next
assessed the activation status of phagocytes following uptake
of necroptotic corpses in the presence of absence of ongoing
translation. We found that phagocytes that had taken up necrop-
totic material (FluoSphere+) displayed increased expression of
the activation markers MHC-II and CD-80 relative to phagocytes
within the same culture that had not but that this phagocyte acti-
vation occurred irrespective of continued translation (Fig-
ure S5C), and importantly, the uptake of emetine-treated cells
did not affect the number or viability of BMDM cells in vitro.
Together, these findings imply that ongoing production of
inflammatory mediators promotes localization and uptake of
necroptotic cells by phagocytes but that other signals promote
activation of these phagocytes following dead cell encounter.
We next used a similar experimental approach to assess the
role of ongoing cytokine production in the uptake and trafficking
material derived from necroptotic cell corpses in vivo. To do this,
we injected FluoSphere-labeled corpses (verified >95% per-
meabilized PMs by flow at time of injection; data not shown),
with or without emetine pulse, into the footpads of mice and
then analyzed FluoSphere-positive phagocytes in the draining
lymph node 24 h later (Figure 5A). We observed a similar number
of FluoSphere-positive myeloid cells in the draining lymph nodes
(dLNs) of mice that received either actively dying cells (cells
induced to undergo necroptosis in situ, as we have previously
described; Yatim et al., 2015) or corpses; however, there were
significantly fewer FluoSphere-positive cells in the dLNs of those
animals that received emetine-pulsed corpses (Figure 5C). We
also observed a decreased number of FluoSphere-positive
migratory dendritic cells (DCs) (as defined by CD11c+ MHCIIhi
myeloid cells) in the dLNs of animals that received emetine-
treated corpses relative to animals that received either corpses
in which continued cytokine synthesis was occurring or when
cells underwent necroptosis in situ (Figure 5D). However, no dif-
ference was observed in the total number of myeloid cells pre-
sent in the dLNs across treatment groups (Figure S5D). These
data suggest that signals generated by translation of inflamma-
tory mediators in necroptotic cells at peripheral sites can
contribute to the efficient uptake and trafficking of material
derived from necroptotic cells to the dLN.Cell Reports 28, 2275–2287, August 27, 2019 2283
Figure 5. Preservation of Translation Capacity in Necroptotic Cell Corpses InfluencesMyeloid Cell Trafficking and Cross-Priming of Antigen
Derived from Necroptotic Cells
(A) Experimental schematic for (B)–(E). (B) Bone-marrow-derived macrophages (BMDM) were incubated with FluoSphere-labeled necroptotic cell corpses that
had or had not been transiently treated with emetine. After 6 h, BMDMs that had taken up dead cell material were quantified by flow cytometry.
(C and D) Percentage and total number of FluoSphere-positive myeloid cells (CD3B220CD11b+; C) or migratory dendritic cells (CD11c+MHCIIhi; D) in the
draining lymph node (popliteal) of mice, 24 h after injection in the footpad.
(E) NIH 3T3 cells expressing membrane-bound OVA (either actively dying in vivo [necroptosis in situ], corpses, or corpses pulse-treated with emetine) were
injected into C57BL/6 mice. 9 days later, OVA-specific (SIINFEKL-H2Kb tetramer+) and activated (CD44+CD62L) CD8+ T cell responses were measured by flow
cytometry.
Data in (B) are representative of three independent experiments; data in (C)–(E) each represent two independent experiments combined. *p < 0.05; **p < 0.01;
****p < 0.0001. Error bars indicate SD from the mean.
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Previously, we reported that NF-kB activity downstream of
RIPK3 activation promotes the cross-priming of CD8+ T cell re-
sponses against antigen derived from necroptotic cells (Yatim
et al., 2015). We hypothesized that ongoing translation of inflam-
matory mediators following PM rupture could contribute to the
cross-priming potential of these corpses in vivo. To address
this, we immunized C57BL/6 mice with cells containing mem-
brane-bound ovalbumin (mOVA) and compared immunization
with cells undergoing necroptosis in situ, with corpses in which
translation was ongoing, or with emetine-pulsed corpses in
which translation was abrogated. Nine days later, we enumer-
ated OVA-specific CD8+ T cells as a measure of the cross-prim-
ing response elicited by each dying cell treatment. Mice that
received either actively dying necroptotic cells or corpses
showed efficient cross-priming and had no significant difference
in the number of OVA-specific CD8+ T cells or activated CD8+
T cells; however, mice that received emetine-treated corpses
had significantly fewer antigen-specific cells and activated
CD8+ T cells (Figure 5E). This finding suggests that the continued
production of inflammatory mediators promotes a robust cross-
priming response in vivo. Together, these data indicate that the
continued production of inflammatory cytokines and chemo-
kines by necroptotic cell corpses promotes the trafficking of nec-
roptotic cell-derived antigens to draining lymph nodes and the
initiation of T cell responses to dying cell-derived antigen.
DISCUSSION
Several recent reports have indicated that activation of the nec-
roptotic pathway is associated with inflammatory transcription
as well as with cell death (Orozco et al., 2014; Yatim et al.,
2015). However, how the terminal process of cell death is coor-
dinated with the production of cytokines and chemokines, two
apparently opposing cellular processes, is poorly understood.
Here, we report that necroptotic corpses can continue protein
translation even after loss of PM integrity. We observed this
phenomenon downstream of either direct RIPK3 activation or
necroptosis in response to TNF-a or infection with MCMV or
influenza A virus (IAV). This phenomenon contrasts with
apoptotic cell death, during which protein synthesis is actively
antagonized through caspase-mediated destruction of the
translationmachinery (Clemens et al., 2000). Indeed, our findings
are consistent with a previous report, which indicated that direct
disruption of the protein synthesis machinery is a feature of
apoptosis that does not occur during necroptosis (Saelens
et al., 2005). Although that report indicated that protein synthesis
in necroptotic cells could continue up to the point of PM disrup-
tion, our data extend these observations by demonstrating that
protein synthesis occurs even after the cell has irreversibly lost
PM integrity and would be considered dead by commonly
used measures of cell death. Our work supports the idea that
MLKL leaves the ER network intact during necroptosis, thus al-
lowing translation to continue; notably, we demonstrate here
that forced targeting of MLKL to the ER disrupts translation
without affecting the execution of MLKL-dependent cell death.
Protein translation is energy intensive, and necroptotic cells
release ATP upon PM lysis. However, we found that necroptotic
cell corpses sustained low levels of ATP up to 12 h after PM lysis.Although the physiological concentration of ATP in cells is quite
high (Traut, 1994), a recent study suggested that this does not
reflect the energetic needs of the cell but rather that high ATP
concentration is required for proper protein folding and solubility
(Patel et al., 2017), and protein synthesis can occur at much
lower ATP concentrations (Jewett et al., 2009). We speculate
that the residual ATP present in necroptotic corpses is sufficient
to power the limited translation we observe in these cells.
Previous work has suggested that necroptosis can actually
dampen inflammatory responses by eliminating cells that would
otherwise continue cytokine synthesis in response to TNF-a or
lipopolysaccharide (LPS) (Kearney et al., 2015). Our data do
not contradict this idea, as the total magnitude of inflammatory
mediators produced by a live cell in response to these stimuli
would outstrip the post-death production we observe. Nonethe-
less, our data suggest that cytokines and chemokines produced
after cell lysis are an important contributor to the inflammatory
and immune response to necroptotic cells.
We speculate that the necroptotic program evolved as an anti-
viral mechanism, allowing elimination of the replicative niche by
destroying the PM, while continuing cytokine and chemokine
production to alert the immune system and recruit relevant im-
mune cells to the site of infection (Daniels et al., 2017). A further,
non-exclusive possibility is that viral proteins can also be trans-
lated in necroptotic corpses, thereby loading the necroptotic
corpse with viral antigen. As we have previously shown that an-
tigens derived from necroptotic cells more readily cross-prime
CD8+ T cells (Yatim et al., 2015), this mechanism could
contribute to the induction of antiviral immune responses.
Together, our findings indicate that the necroptotic program in-
volves the coordination of cell death with continued cytokine
synthesis and that this property contributes to the inflammatory
and immunogenic nature of necroptosis.STAR+METHODS
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Zombie Green Fixable Viability Dye BioLegend Cat# 423111
Zombie Aqua Fixable Viability Dye BioLegend Cat# 423101
Murine TNFa Peprotech Cat# 315-01A
zVAD SM Biochemicals Cat# SMFMK001
GSK’843 GlaxoSmithKline N/A
Necrostatin-1 Sigma-Aldrich Cat# N9037
Dimerizer (B/B homodimerizer) Clontech Cat# 635069
B/B Washout Ligand Clontech Cat# 635088
Actinomycin D Sigma-Aldrich Cat# A1410
Cycloheximide Sigma-Aldrich Cat# C7698
Gelonin Enzo Life Sciences Cat# ALX-350-150-M001
Digitonin EMD Millipore Cat# 300410
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER
Thapsigargin Thermo Fisher Cat# T7458
Brefeldin A BioLegend Cat# 420601
Puromycin dihydrochloride Thermo Fisher Cat# A1113803
Paraformaldehyde Fisher Cat# 50-980-487
Emetine dihydrochloride EMD Millipore Cat# 324693
Yellow-green FluoSpheres Thermo Fisher Cat #F8795
HALT Protease Inhibitor Cocktail Thermo Fisher Cat# 78429
DAPI Thermo Fisher Cat #62248
Critical Commercial Assays
IL-6 Mouse ELISA Kit Thermo Fisher Cat# 88-7064-76
MCP-1/CCL2 Mouse ELISA Kit Thermo Fisher Cat# 88-7391-76
Murine KC (CXCL1) Standard ELISA Development Kit Peprotech Cat# 900-K127
Murine MIP-2 (CXCL2) Standard ELISA Development Kit Peprotech Cat# 900-K152
CellTiter-Blue Viability Assay Promega Cat# G8080
Pierce LDH Cytotoxicity Assay Kit Thermo Fisher Cat# 88954
CellTiter-Glo Promega Cat# G7572
TNT Quick Coupled Transcription/Translation System Promega Cat# L1171
Deposited Data
RNA sequencing datasets NIH GEO repository GSE134234
Experimental Models: Cell Lines
Mouse: NIH 3T3 + acRIPK3 Orozco et al., 2014;
Yatim et al., 2015
N/A
Mouse: NIH 3T3 + acRIPK3 + mOVA-mCherry This paper N/A
Mouse: NIH 3T3 + acRIPK3 + MLKL-ERcb5 This paper N/A
Mouse: SVEC4-10 + scramble gRNA (CRISPR/Cas9) This paper N/A
Mouse: SVEC4-10 + RIPK3 gRNA (CRISPR/Cas9) This paper N/A
Experimental Models: Organisms/Strains
C57BL/6J Jackson Laboratory Stock# 000664
Oligonucleotides
See Table S1 N/A N/A
Recombinant DNA
Plasmid: acRIPK3 in pBabe-puromycin Orozco et al., 2014;
Yatim et al., 2015
N/A
Plasmid: Membrane-bound OVA (mOVA)-t2A-mCherry in pBabe-
puromycin
This paper N/A
Plasmid: MLKL-ERcb5 in pSLIK-Hygromycin This paper N/A
Plasmid: scramble (non-targeting) gRNA in pRRL-Cas9-t2a-
puromycin
This paper N/A
Plasmid: RIPK3 gRNA in pRRL-Cas9-t2a-puromycin This paper N/A
Software and Algorithms
Prism version 7 GraphPad Software https://www.graphpad.com
FlowJo version 10 FlowJo, LLC https://www.flowjo.com
LoggerPro Software Vernier https://www.vernier.com
ImageJ NIH https://imagej.nih.gov/ij
Other
2-color IncuCyte Zoom in-incubator imaging system Essen Bioscience N/A
BD LSRII Flow Cytometer BD Biosciences N/A
SW40 Ti Rotor Beckman Coulter N/A
Auto-Densi Flow Pump Labconco N/A
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER
Foxy R2 Fraction Collector Teledyne Isco N/A
UA-6 UV Detector Teledyne Isco N/A
ViiA7 Real-Time PCR System Applied Biosystems N/ALEAD CONTACT AND MATERIALS AVAILABILITY
Plasmids and cell lines generated in this study will be made available under a standard material transfer agreement. Requests for
resources and reagents should be directed to and will be fulfilled by the Lead Contact, Andrew Oberst (oberst@uw.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
Wild-type C57BL/6J mice were obtained commercially (Jackson Laboratories) and were housed under specific-pathogen-free con-
ditions at the University of Washington. All experiments were performed in female 6-8 week-old mice, in accordance with protocols
approved by the University of Washington Animal Care and Use Committee (IACUC).
Cell Culture
NIH 3T3 cells (ATCC) and SVEC4-10 cells (ATCC), as well as derived cell lines (NIH 3T3 + acRIPK3, NIH 3T3 + acRIPK3 + MLKL-
ERCb5, SVEC4-10 + scramble gRNA, SVEC4-10 + RIPK3 gRNA), were maintained in D-MEM supplemented with 10% FBS, 29.2
g/l glutamine, 10 000 U/ml penicillin and 10 000 mg/ml streptomycin, and grown at 37C in 5% CO2.
METHOD DETAILS
NIH 3T3 + acRIPK3 Cell Line Generation
The acRIPK3 chimeric protein was constructed as previously described (Orozco et al., 2014; Yatim et al., 2015). Briefly, full-length
murine RIPK3 was cloned upstream of 2 copies of FKBP carrying the F36V mutation. When two FKBPF36V domains were used, the
first copy contained silentmutations to prevent DNA recombination. TheseRIPK3- FKBPF36V fusion proteins were cloned into pBabe-
Puromycin retroviral vectors. This construct was transduced into NIH 3T3 cells (ATCC) using standard protocols for helper-depen-
dent retroviral transduction. Transduced cells were selected for 5 days in 1 mg/ml puromycin, then single-cell cloned to obtain a
homogeneous population.
NIH 3T3 + acRIPK3 + MLKL-ERcb5 Cell Line Generation
MLKL-ERcb5 was cloned into the previously described doxycycline-inducible pSLIK-Hygromycin backbone (Yatim et al., 2015). This
construct was transduced into NIH 3T3 cells expressing acRIPK3. Transduced cells were selected for 7 days in 200 mg/ml hygrom-
ycin B.
Generation of CRISPR/Cas9 Gene-Edited SVEC4-10 Cell Lines
For CRISPR/Cas9-genome editing of SVEC4-10 cells (ATCC), guide RNA (gRNA) sequences were cloned into the lentiviral construct
pRRL-Cas9-T2A-puromycin which encodes both a guide RNA (gRNA) (Gray et al., 2016) targeting either the Ripk3 gene, or a murine
non-targeting gRNA (Sanjana et al., 2014) as well as the Cas9 enzyme. Guide RNA sequences are presented in Table S1. Lentiviral
particles were created using these constructs, and this virus was used to transduce SVEC4-10 cells using standard lentiviral trans-
duction protocols. Transduced cells were selected for 5 days in 1 mg/ml puromycin, and validated via western blot analysis.
Cell death assays
Cell death was quantified by flow cytometry on an LSRII Flow Cytometer (BD) or using a 2-color IncuCyte Zoom in-incubator imaging
system (Essen Biosciences) as previously described (Orozco et al., 2014). Dead cells were detected by uptake of the cell-imperme-
able dye Sytox Green (Thermo Fisher). Cell death was also quantified by either CellTiter-Blue Cell Viability Assay (Promega) or LDH
Cytotoxicity Assay (Thermo Fisher), both according to manufacturer’s instructions. To assess ATP levels in necroptotic corpses,
CellTiter-Glo (Promega) was used according to the manufacturer’s instructions.
Electron microscopy
NIH 3T3 cells were induced to undergo necroptosis for 3 h; following treatment, sampleswere fixed in 2.5%glutaraldehyde, 2%para-
formaldehyde in 0.1 M sodium cacodylate buffer pH 7.4, and postfixed for 1.5 h in reduced 2% osmium tetroxide with 1.5% potas-
sium ferrocyanide in 0.1 M sodium cacodylate buffer. After rinsing in buffer, samples were dehydrated through a series of gradede3 Cell Reports 28, 2275–2287.e1–e5, August 27, 2019
ethanol to propylene oxide solutions, infiltrated and embedded in epoxy resin, and polymerized at 70Covernight. Semi-thin sections
(0.5micron) were stained with toluidine blue for light microscopic examination. Ultra-thin sections (80 nm) were cut and imaged using
the Tecnai TF20 TEM with an AMT XR41 camera.
Polysome Analysis and qRT-PCR
Polysome analysis was performed as previously described (Chasse´ et al., 2017). Briefly, cells were treated for 4 hwith either 20 ng/mL
TNFa (Peprotech) or 500 nM dimerizer (Clontech), and then treated with 100 mg/mL of cycloheximide (Sigma-Aldrich) or 25mMEDTA
for 5 min at 37C. Cells were then pelleted and lysed in hypotonic lysis buffer (5 mM Tris-HCl pH 7.5, 2.5 mMMgCl2, 1.5 mMKCl, and
1X protease inhibitor cocktail) followed by addition of 100 mg/mL cycloheximide, 2 mM DTT, 200 U/mL RNasin, 0.5% Triton-X, and
0.5% sodium deoxycholate. Lysates were clarified by spinning at max speed in a tabletop centrifuge for 5 min, and supernatants
were loaded onto sucrose gradients (10%–50%). Samples were then ultracentrifuged using an SW40 Ti Rotor (Beckman Coulter)
for 2 h at 4C. Gradients were fractionated using an Auto-Densi Flow Pump (Labconco) and a Foxy R2 Fraction Collector (Teledyne
Isco), while continuously monitoring absorbance at 254 nm using UA-6 UV detector and LoggerPro Software (Vernier).
RNA was extracted from the fractions corresponding to polysomes using RNA Stat-60 (Amsbio); RNA fractions from each sample
were then pooled, and cDNA was made using SuperScript III Reverse Transcriptase (Thermo Fisher). Quantitative real-time PCR
(qRT-PCR) analysis was performed using SYBR Green (Thermo Fisher) and ViiA7 Real-Time PCR System (Applied Biosystems).
Cytokine and Gapdh transcripts were quantified against a standard curve of known amounts.
RNA sequencing
QC of total RNA was done to determine their quantity and quality. The concentration of RNA samples was determined using
NanoDrop 8000 (Thermo Scientific) and the integrity of RNA was determined by Fragment Analyzer (Advanced Analytical Technol-
ogies). 0.1ug of total RNA was used as an input material for library preparation using TruSeq Stranded Total RNA Library Prep Kit
(Illumina). Size of the libraries was confirmed using 4200 TapeStation and High Sensitivity D1K screen tape (Agilent Technologies)
and their concentration was determined by qPCR based method using Library quantification kit (KAPA). The libraries were multi-
plexed and sequenced on Illumina HiSeq4000 (Illumina) to generate 30M of single end 50 base pair reads.
Immunocytochemistry
Fluorescent immunocytochemistry was performed as previously described (Daniels et al., 2017). Cells were fixed for 15 min with 4%
paraformaldehyde (Fisher), permeabilized with 0.1% Triton-X, and blocked with 10% goat serum. Cells were stained using primary
anti-puromycin (Clone 12D10, EMD Millipore) or anti-ERp72 (Cell Signaling Technologies) for 1 h at room temperature, followed by
secondary goat anti-mouse AlexaFluor594 (Abcam) or goat anti-rabbit AlexaFluor405 (Abcam). Dead cells were visualized via stain-
ing with the fixable viability dye Zombie Green (BioLegend).
Cytokine Protein Quantification in Cell Supernatants
104 NIH 3T3 cells were plated per well in a 96-well tissue culture plate the day prior to treatment. Cells were then treated with 100 nM
dimerizer and different combinations of inhibitors (as per figure legends) in a 200 mL volume. Supernatants were collected and clar-
ified by centrifugation at various time points, and stored at 80C. Cytokine concentrations in cell culture supernatants were
measured using IL-6 (Thermo Fisher), CXCL2 (Peprotech), CXCL1 (Peprotech) or CCL2 (Thermo Fisher) ELISA kits, according to
the manufacturer’s protocols.
Western Blots
Cells were lysed in NP-40 lysis buffer (150 mMNaCl, 20 mM tris-Cl, 1 mM EDTA, 1%NP-40 at pH 7.5) with 1X Halt Protease Inhibitor
Cocktail (Thermo Fisher). 30 mg of protein was run on a 4%–20% Novex Tris-Glycine mini gel (Fisher) at 125 V for 2 h in WB running
buffer (24mM tris, 32mMglycine, 3.5mMSDS) and transferred onto PVDFmembrane (Thermo Fisher) at 300mAmps for 1 h in trans-
fer buffer (6mM tris, 8mMglycine, 15%methanol). Membranes were blocked in 5%drymilk in TBS-Tween20 (1%) for 30min at room
temperature. Membranes were incubated overnight at 4C with primary anti-RIPK3 (Novus Biologicals), anti-V5 (Thermo Fisher) or
anti-actin (EMD Millipore), followed by staining with HRP-conjugated secondary antibodies (Santa Cruz). Membranes were devel-
oped using ECL Western Blotting Substrate (Pierce) and film.
In vitro transcription/translation
TNT Quick Coupled Transcription/Translation System (Promega) was used to assess the effects of compounds on translation in a
cell-free system. A construct template coding for V5-tagged TEV was used with the kit, according to manufacturer’s instructions.
Lysates were analyzed via western blot.
In Vivo Migration Assays
NIH 3T3 cells were loaded with 106 particles/cell of FluoSpheres (Thermo Fisher) for one h at 37C. Excess FluoSpheres were aspi-
rated and cells were washed once with 1X PBS, then treated with 500 nM dimerizer for 3 h or pulsed for 15 min at 37C as previously
described (Yatim et al., 2015). Corpses were then treated with 25 mg/mL of emetine (EMD Millipore) or vehicle (water) for 15 min atCell Reports 28, 2275–2287.e1–e5, August 27, 2019 e4
37C, and washed 2x with 1X PBS. 5x105 cells or corpses were injected into each rear footpad of naive C57BL/6 mice. 24 h later,
animals were sacrificed and the draining (popliteal) lymph nodes were harvested; single cell suspensions were made and stained
for flow cytometric analysis.
In Vivo Cross-priming Assays
NIH 3T3 + acRIPK3 cells expressing membrane-bound ovalbumin (mOVA) were treated with 500 nM dimerizer for 3 h or pulsed for
15 min at 37C as previously described (Yatim et al., 2015). Corpses were then treated with 25 mg/mL or emetine or vehicle (water) for
15 min at 37C, and washed 2x with 1X PBS. One million cells were injected into the flank of naive C57BL/6 female mice, and nine
days later, animals were sacrificed and spleen and draining (inguinal) lymph nodes were harvested and pooled. Single cell suspen-
sions weremade and cells were stained for OVA tetramer (SIINFEKL-H2Kb), and activationmarkers; cells were fixed and analyzed by
flow cytometry.
Flow cytometric analysis
Cell viability was assessed by staining with Zombie Green (BioLegend) or Zombie Aqua (BioLegend), diluted 1:1000 in PBS and incu-
bated at 4C for 30 min. For surface staining, cells were first incubated with anti-CD16/CD32 receptor antibody (BD clone 2.4G2)
diluted 1:100 in PBS, for 30 min at 4C. Cells were then stained with fluorescently conjugated antibodies diluted 1:100 in PBS for
1 h at 4C; cell suspensions were stained with antibodies to CD3 (BD clone 145-2C11), B220 (BD clone RA3-6B2), CD4 (BD clone
RM4-5), CD8a (BD clone 53-6.7), CD44 (BD clone IM7), CD62L (BD clone MEL-14), CD11b (BD clone M1/70), CD11c (BD clone
N418), MHCII I-A/E (BD clone M5/114.15.2), F4/80 (BD clone T45-2342), and SIINFEKL-H2Kb tetramer (NIH Tetramer Core).
For intracellular staining, cells were fixed with BD Perm/Fix for 20 min at 4C, and then permeabilized with BD Perm/Wash for
10min at 4C. Cells were stained intracellularly with fluorescently conjugated antibodies to CCL2 (BD clone 2H5) and IL-6 (BioLegend
clone MP5-20F3), diluted 1:100 in BD Perm/Wash, for 1 h at 4C.
All flow cytometry was performed on a BD LSRII flow cytometer. FlowJo (Tree Star, Inc.) software was used for all flow cytometric
analysis.
QUANTIFICATION AND STATISTICAL ANALYSIS
Experimental replicate information is indicated in the figure legends. All results are given as mean ± SD and analyzed by using sta-
tistical tools in GraphPad Prism software (La Jolla, CA). For in vivo experiments, unpaired t test (for percentage) or Mann-Whitney test
(for total cell numbers) were used. For protein quantification by ELISA, unpaired t tests were used. Differences with p < 0.05 were
considered significant.
RNA Seq Differential analysis
FASTQ files were aligned to themouse reference genome (mm9) using the GSNAP alignment tool. The count data from the alignment
was normalized to rpkm and then filtered to remove lowly expressed genes. The resulting expression data were then adjusted by
library size and corrected with voom precision weights. The differential expression analysis was performed using limma by defining
the adequate contrasts and using the ebayesmethod. The resulting p values were adjusted by false discovery rate correction and the
top deferentially expressed genes were ranked by fold change. All the analyses were conducted using R version 3.5.0.
DATA AND CODE AVAILABILITY
Complete RNA sequencing datasets are available via the NIH Gene Expression Omnibus (GEO) site (https://www.ncbi.nlm.nih.gov/
geo), Series Record GSE134234.e5 Cell Reports 28, 2275–2287.e1–e5, August 27, 2019
